Balanced news tone
News Sentiment
MYX sentiment intelligence
Mayne Pharma Group Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
+4.0% over one week, +19.1% over four weeks, trend inactive, and below fair value.
Mayne Pharma Group (ASX:MYX) Rises 3.55%: What's Behind the Pharma Stock's Move?
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Mayne Pharma Group (ASX:MYX) Rises 3.55%: What's Behind the Pharma Stock's Move?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 10:30
- Source
- Kalkine
Private equity kicked the tyres at Mayne’s Adelaide plant, but no dice
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 05:36
- Source
- AFR
What’s Driving Fresh Interest in Mayne Pharma (ASX:MYX) Shares?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jun 2026 07:00
- Source
- Kalkine
Mayne Pharma Group Receives AU$14.4 Million From Cosette Pharmaceuticals for Legal Costs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Moomoo
Mayne Pharma Group (ASX:MYX) Shares Under Pressure as Deep Losses Continue to Weigh on Sentiment
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Kalkine
Health Check: We will duck Donald’s tariffs, say CSL and Mayne Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- Stockhead
Mayne Pharma Group (ASX:MYX) Faces Selling Pressure: What to Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2026 07:00
- Source
- Kalkine
Mayne Pharma Group H1 2026 Loss Narrowing Tests Bearish Narratives On Profitability Path
- Tone
- Negative 18/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- simplywall.st
Mayne Pharma to return to court to fight Cosette for failed bid costs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- AFR
Mayne Pharma weighs sale of US operations to unlock shareholder value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jan 2026 08:00
- Source
- Capital Brief
Mayne Pharma under earnings pressure after failed takeover deal
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Dec 2025 08:00
- Source
- AFR
Australian government rejects Cosette's proposed Mayne Pharma buyout, citing 'national interest'
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Nov 2025 08:00
- Source
- Fierce Pharma
Chalmers kills $672m Mayne takeover on national interest grounds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Nov 2025 08:00
- Source
- AFR
Mayne Pharma shares surge on Takeovers Panel's ruling
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- Proactive financial news
Australia Blocks U.S.-Based Cosette’s $387.2 Million Takeover of Mayne Pharma
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- WSJ
Australian Shares Fall; Australia Blocks Cosette's Proposed Mayne Pharma Acquisition on National Interest Grounds
- Tone
- Negative 22/100
- Event
- Deals and strategy
- Published
- 20 Nov 2025 08:00
- Source
- Market source
Mayne Pharma Collapses 30% as Treasurer Flags National-Interest Block in Cosette Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 31 Oct 2025 07:00
- Source
- Stocks Down Under
Shareholders, lawyers slam move to kill Mayne Pharma takeover bid
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Oct 2025 07:00
- Source
- AFR
Court blocks Cosette's attempt to drop $438 million Mayne deal; shares jump
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Oct 2025 07:00
- Source
- Reuters
How the fight over $672m pharma deal became a 'watershed' moment for ASX takeovers
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Sep 2025 07:00
- Source
- Capital Brief
Inside Mayne Pharma suitor’s battle to sink Project Crocodile
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Sep 2025 07:00
- Source
- AFR